CYP21A2 NM_000500.9(CYP21A2):c.293-13C>G

CI-VAR-00006006Explore in graph →NM_000500.9:c.293-13C>GClinVar 12155 rs6467

Curated evidence

Evidence by cancer (0 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

Data not yet available

No curated evidence item references this variant yet.

ClinVar

Clinical significance (1)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

clinvarCurated1 interpretation · review status and star rating as assigned by ClinVar.

Variation	Clinical significance	Review status	Stars	Conditions	Origin	Submitters	Last evaluated	Source
12155	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	2	21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia; Inborn genetic diseases; Congenital adrenal hyperplasia; Fetal anomalies with a likely genetic cause; Ovarian serous cystadenocarcinoma; Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency; CYP21A2-related disorder	germline	46	Aug 12, 2026	clinvar